dsm-firmenich stock: Q3 Growth Lifts 2026 Sales Outlook

Published on 11/04/2026 at 17:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

dsm-firmenich stock gained a stronger full-year sales outlook after volume-led third-quarter growth. Management kept its margin and cash targets intact.

Growth Outlook Moves Higher

Third-quarter like-for-like sales rose 5% on volume-led momentum.
Adjusted EBITDA increased 8% like-for-like, while the quarterly margin reached 20.4%.
The company remains focused on cost savings, cash conversion and its 2027-2028 targets.

DSM-Firmenich, CH1216478797, Illustration mit AI erstellt.

dsm-firmenich raised its full-year sales outlook on Wednesday, November 4, 2026, after reporting volume-led growth in the third quarter. The company now expects like-for-like sales growth of around 5% for 2026, up from its previous range of 2% to 4%.

The company announced the update in its Q3 2026 trading update. Like-for-like sales rose 5% in the quarter, matching the year-to-date rate, as customer wins and innovation supported demand across the portfolio.

Margin Progress Supports the Plan

Adjusted EBITDA increased 8% on a like-for-like basis. The adjusted EBITDA margin reached 20.4% in the quarter, with the company describing this as a sequential improvement. Foreign-exchange movements had an 80-basis-point negative effect compared with the third quarter of 2025.

For the full year, dsm-firmenich kept its adjusted EBITDA margin target at around 20%. It also maintained its adjusted gross operating free cash flow to sales target at 11% to 12%. Management said cost savings, restructuring and further pricing actions remain central to offsetting cost inflation.

Business Units Set the Next Test

dsm-firmenich said all three continuing business units contributed to the quarter. The group is concentrating on Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care after the planned divestment of Animal Nutrition & Health.

The company said its 2026-2028 action plan remains on track and that business conditions were supportive entering the fourth quarter. Investors will focus next on whether volume growth, customer wins and cost discipline can convert the upgraded sales outlook into sustained margin expansion.